These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 23148161)

  • 21. Effects of short chain fatty acid producing bacteria on epigenetic regulation of FFAR3 in type 2 diabetes and obesity.
    Remely M; Aumueller E; Merold C; Dworzak S; Hippe B; Zanner J; Pointner A; Brath H; Haslberger AG
    Gene; 2014 Mar; 537(1):85-92. PubMed ID: 24325907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Duodenal enteroendocrine I-cells contain mRNA transcripts encoding key endocannabinoid and fatty acid receptors.
    Sykaras AG; Demenis C; Case RM; McLaughlin JT; Smith CP
    PLoS One; 2012; 7(8):e42373. PubMed ID: 22876318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular characterization of free fatty acid receptors FFAR2 and FFAR3 in the domestic cat.
    Yamamoto I; Kawasumi K; Ohkusu-Tsukada K; Arai T
    Vet Med Sci; 2021 Jan; 7(1):77-85. PubMed ID: 32929853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of duodenal expression and localization of fatty acid-sensing receptors in humans: relationships with body mass index.
    Little TJ; Isaacs NJ; Young RL; Ott R; Nguyen NQ; Rayner CK; Horowitz M; Feinle-Bisset C
    Am J Physiol Gastrointest Liver Physiol; 2014 Nov; 307(10):G958-67. PubMed ID: 25258406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Free Fatty Acid Receptor Family: A New Therapeutic Target for Metabolic Diseases].
    Hirasawa A
    Yakugaku Zasshi; 2015; 135(6):769-77. PubMed ID: 26028412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of metabolic sensing receptors in adipose tissues of periparturient dairy cows with differing extent of negative energy balance.
    Friedrichs P; Sauerwein H; Huber K; Locher LF; Rehage J; Meyer U; Dänicke S; Kuhla B; Mielenz M
    Animal; 2016 Apr; 10(4):623-32. PubMed ID: 26556304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fatty acid signaling in the beta-cell and insulin secretion.
    Nolan CJ; Madiraju MS; Delghingaro-Augusto V; Peyot ML; Prentki M
    Diabetes; 2006 Dec; 55 Suppl 2():S16-23. PubMed ID: 17130640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FFAR2-FFAR3 receptor heteromerization modulates short-chain fatty acid sensing.
    Ang Z; Xiong D; Wu M; Ding JL
    FASEB J; 2018 Jan; 32(1):289-303. PubMed ID: 28883043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Free Fatty Acid Receptors in Health and Disease.
    Kimura I; Ichimura A; Ohue-Kitano R; Igarashi M
    Physiol Rev; 2020 Jan; 100(1):171-210. PubMed ID: 31487233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic effects of orally administered small-molecule agonists of GPR55 and GPR119 in multiple low-dose streptozotocin-induced diabetic and incretin-receptor-knockout mice.
    McKillop AM; Moran BM; Abdel-Wahab YH; Gormley NM; Flatt PR
    Diabetologia; 2016 Dec; 59(12):2674-2685. PubMed ID: 27677765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent advances in gut nutrient chemosensing.
    Nguyen CA; Akiba Y; Kaunitz JD
    Curr Med Chem; 2012; 19(1):28-34. PubMed ID: 22300073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. G-protein coupled receptors mediating long chain fatty acid signalling in the pancreatic beta-cell.
    Morgan NG; Dhayal S
    Biochem Pharmacol; 2009 Dec; 78(12):1419-27. PubMed ID: 19660440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent Advances in Development of GPR40 Modulators (FFA1/FFAR1): An Emerging Target for Type 2 Diabetes.
    Sharma N; Bhagat S; Chundawat TS
    Mini Rev Med Chem; 2017; 17(11):947-958. PubMed ID: 28117025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short-chain fatty acid sensing in rat duodenum.
    Akiba Y; Inoue T; Kaji I; Higashiyama M; Narimatsu K; Iwamoto K; Watanabe M; Guth PH; Engel E; Kuwahara A; Kaunitz JD
    J Physiol; 2015 Feb; 593(3):585-99. PubMed ID: 25433076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short chain fatty acids and their receptors: new metabolic targets.
    Layden BT; Angueira AR; Brodsky M; Durai V; Lowe WL
    Transl Res; 2013 Mar; 161(3):131-40. PubMed ID: 23146568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis, and biological evaluation of novel thiazolidinediones as PPARγ/FFAR1 dual agonists.
    Darwish KM; Salama I; Mostafa S; Gomaa MS; Helal MA
    Eur J Med Chem; 2016 Feb; 109():157-72. PubMed ID: 26774923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short chain fatty acids stimulate insulin secretion and reduce apoptosis in mouse and human islets in vitro: Role of free fatty acid receptor 2.
    Pingitore A; Gonzalez-Abuin N; Ruz-Maldonado I; Huang GC; Frost G; Persaud SJ
    Diabetes Obes Metab; 2019 Feb; 21(2):330-339. PubMed ID: 30203438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug discovery opportunities and challenges at g protein coupled receptors for long chain free Fatty acids.
    Holliday ND; Watson SJ; Brown AJ
    Front Endocrinol (Lausanne); 2011; 2():112. PubMed ID: 22649399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular pharmacology of promiscuous seven transmembrane receptors sensing organic nutrients.
    Wellendorph P; Johansen LD; Bräuner-Osborne H
    Mol Pharmacol; 2009 Sep; 76(3):453-65. PubMed ID: 19487246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fatty acid binding receptors and their physiological role in type 2 diabetes.
    Swaminath G
    Arch Pharm (Weinheim); 2008 Dec; 341(12):753-61. PubMed ID: 19009545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.